223 - MANAGING THE WOMAN AT RISK

Friday, October 25, 2024

9:45 AM – 10:45 AM PT

Room: 205-207

Workshop Description: Cardiovascular disease in women presents unique challenges. Risk factors may be different than men.
Myocardial infarction with no obstructive coronary artery disease (MINOCA) represent 6-15% of MIs and is more common in women. Etiology's include missed plaque rupture, emboli, spontaneous coronary artery dissection, vasospasm, and coronary microvascular dysfunction.
Women experience menopausal symptoms that effect their quality of life -often not discussed with CV specialists. Menopausal Hormone Therapy (MHT) has increased risk of thrombosis with a complicated biology and effect on the vascular system. There is evidence to guide clinicians regarding MHT.
Atrial fibrillation (AF) has unique risk factor profile in women, and consequences of AF are sex specific. Sex disparities are seen in the management of AF as well. Recognizing and addressing these gender and sex-specific issues is essential in managing and preventing cardiovascular disease among women.
In this workshop, the audience will learn key strategies for managing the women at risk through case-based patient scenarios.

Interactive and Engagement Activities Description: three, interesting CV scenarios with sex specific issues, and disparity in care, will be addressed. Case presentations with polling for the audience in addition to Q & A will be used to engage the audience.

Learning Objectives:

At the end of this session participants will be able to:

have a contemporary approach to evaluation of women with MINOCA;
understand the CV Risks associated with Menopausal Hormone Therapy for our female patients;
understand the role of Menopausal Hormone Therapy for symptomatic women;
understand the epidemiology and sex specific risk for women with at atrial fibrillation; and
understand risks for atrial fibrillation and how to manage these risks in older women.

Disclosure(s):

Shuangbo Liu, MD, FRCPC: No financial relationships to disclose

Stephanie Poon, MD: Bayer: Member of speaker's bureau (Ongoing); Boehringer Ingelheim: Member of heart failure advisory board (Ongoing), previous research grant (Ongoing); GSK: Member of advisory board and speaker's bureau (Ongoing); Servier: Member of national heart failure advisory board and speaker's bureaus (Terminated, January 1, 2024)

Beth L. Abramson, MD MSc FRCPC FACC: Amgen: Ad board (Ongoing), Honoraria for CME (Ongoing); Bayer: Ad Board (Ongoing); byosent: Honoraria for CME (Ongoing); HLS: Ad Board (Ongoing), Honoraria for CME (Ongoing); Novartis: Ad board (Ongoing), Honoraria for CME (Ongoing); Novonordisk: Ad Board (Ongoing), honoraria for CME (Ongoing)

Roopinder Sandhu, MD, MPH, FRCPC, FHRS: No financial relationships to disclose

Tara L. Sedlak, MD, FRCPC: Amgen: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Speaker/Honoraria (Ongoing); BI Lilly: Honoraria for talks and ad boards (Ongoing); HLS: Honoraria for talks and ad boards (Ongoing); KYE Pharmaceuticals: Honoraria for talks and ad boards (Ongoing); Norvartis: Honoraria for talks and ad boards (Ongoing); Novo Nordisk: Honoraria for talks and ad boards (Ongoing); Pfizer: Honoraria for talks and ad boards (Ongoing); Sanofi: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (Ongoing)

Daniel Esau, MHSc, MD, FRCPC: Amgen: Consultant/Advisory Board (Terminated), Speaker/Honoraria (Terminated); HLS Therapeutics: Consultant/Advisory Board (Terminated); Novartis: Consultant/Advisory Board (Terminated), Speaker/Honoraria (Terminated); Pfizer: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Speaker/Honoraria (Ongoing)

Karan Saraf, MBChB PhD MRCP CCDS: Amarin Pharmaceuticals: Speaker/Honoraria (Terminated, June 20, 2024); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, August 15, 2023); Medtronic: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, February 1, 2022)

Co-Chair(s)

Shuangbo Liu, MD, FRCPC

Interventional Cardiologist, Assistant Professor
St. Boniface Hospital/University of Manitoba
University of Manitoba
SP

Stephanie Poon, MD

CARDIOLOGIST
CCS, CHFS, CSE
University of Toronto

Panelist(s)

Beth L. Abramson, MD MSc FRCPC FACC

Cardiologist, Paul Albrechtsen Prof. of CV Prevention, U of T
St. Michael's Hospital
University of Toronto
Shuangbo Liu, MD, FRCPC

Interventional Cardiologist, Assistant Professor
St. Boniface Hospital/University of Manitoba
University of Manitoba
Judy Luu, MM, PhD

Assistant Professor,
CSMRI
McGill University
Roopinder Sandhu, MD, MPH, FRCPC, FHRS

Cardiac Electrophysiologist
CHRS
Tara L. Sedlak, MD, FRCPC (she/her/hers)

Cardiologist, Director Leslie Diamond Women’s Heart Health Clinic
Vancouver General Hospital
University of British Columbia

Presenter(s)

Beth L. Abramson, MD MSc FRCPC FACC

Cardiologist, Paul Albrechtsen Prof. of CV Prevention, U of T
St. Michael's Hospital
University of Toronto
Daniel Esau, MHSc, MD, FRCPC

General Internal Medicine
Royal Jubilee Hospital
University of British Columbia
Judy Luu, MM, PhD

Assistant Professor,
CSMRI
McGill University
Roopinder Sandhu, MD, MPH, FRCPC, FHRS

Cardiac Electrophysiologist
CHRS
Karan Saraf, MBChB PhD MRCP CCDS

Fellow in Cardiac Electrophysiology
Libin Cardiovascular Institute
Tara L. Sedlak, MD, FRCPC (she/her/hers)

Cardiologist, Director Leslie Diamond Women’s Heart Health Clinic
Vancouver General Hospital
University of British Columbia

Planning Committee Member(s)

Beth L. Abramson, MD MSc FRCPC FACC

Cardiologist, Paul Albrechtsen Prof. of CV Prevention, U of T
St. Michael's Hospital
University of Toronto
Judy Luu, MM, PhD

Assistant Professor,
CSMRI
McGill University
SP

Stephanie Poon, MD

CARDIOLOGIST
CCS, CHFS, CSE
University of Toronto
Tara L. Sedlak, MD, FRCPC (she/her/hers)

Cardiologist, Director Leslie Diamond Women’s Heart Health Clinic
Vancouver General Hospital
University of British Columbia